Monthly Meetings
October 17, 2019
Topic: SGLT-2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients with Type 2 Diabetes
Speaker: Anniece Spencer, DNP, APRN, FNP-C, BC-ADM
CVMD
Clinical Science Liaison, MO, KS, S.IL
AstraZeneca
US Medical Affairs | CVMD
St. Louis, MO
WHERE
Celebrations Downtown
19 South Spanish
Cape Girardeau, MO 63701
Space Is Limited
To RSVP or for more information, contact John Caldwell, area sales representative, AstraZeneca
or 573-450-9105